奥氮平治疗引发的抗精神病药恶性综合征复发。 - Suppr

Suppr

超能文献

Recurrence of neuroleptic malignant syndrome with olanzapine treatment.

作者信息

Gheorghiu S, Knobler H Y, Drumer D

出版信息

Am J Psychiatry. 1999 Nov;156(11):1836. doi: 10.1176/ajp.156.11.1836.

DOI:10.1176/ajp.156.11.1836

PMID:10553758

Abstract

摘要

相似文献

Recurrence of neuroleptic malignant syndrome with olanzapine treatment.

Am J Psychiatry. 1999 Nov;156(11):1836. doi: 10.1176/ajp.156.11.1836.

Olanzapine usage associated with neuroleptic malignant syndrome.

Psychosomatics. 2001 Nov-Dec;42(6):528-9. doi: 10.1176/appi.psy.42.6.528.

[Life threatening neuroleptic malignant syndrome due to olanzapine].

Psychiatr Prax. 2003 Jul;30(5):279-82. doi: 10.1055/s-2003-40681.

Olanzapine and neuroleptic malignant syndrome.

Psychosomatics. 2002 Nov-Dec;43(6):505-6; author reply 506. doi: 10.1176/appi.psy.43.6.505.

Olanzapine-induced neuroleptic malignant syndrome.

Arch Gen Psychiatry. 1999 Jan;56(1):101-2. doi: 10.1001/archpsyc.56.1.101.

Olanzapine-induced neuroleptic malignant syndrome with mental retardation.

Am J Psychiatry. 1999 Jul;156(7):1115-6. doi: 10.1176/ajp.156.7.1115a.

Neuroleptic malignant syndrome associated with olanzapine.

Ann Pharmacother. 1998 Nov;32(11):1158-9. doi: 10.1345/aph.18151.

Neuroleptic malignant syndrome associated with olanzapine.

Aust N Z J Psychiatry. 1998 Dec;32(6):884-6. doi: 10.3109/00048679809073880.

Neuroleptic malignant syndrome after addition of haloperidol to atypical antipsychotic.

Am J Psychiatry. 2001 Apr;158(4):650-1. doi: 10.1176/appi.ajp.158.4.650-a.

Olanzapine induced "typical" neuroleptic malignant syndrome.

J Clin Psychopharmacol. 2003 Feb;23(1):101-2. doi: 10.1097/00004714-200302000-00016.

引用本文的文献

Three Episodes of Neuroleptic Malignant Syndrome With Risperidone: A Case Report and Literature Review.

Case Rep Psychiatry. 2025 Sep 11;2025:6669246. doi: 10.1155/crps/6669246. eCollection 2025.

Serum creatine kinase elevation as a possible complication of therapy with olanzapine.

Naunyn Schmiedebergs Arch Pharmacol. 2005 Aug;372(2):168-9. doi: 10.1007/s00210-005-0004-7. Epub 2005 Oct 22.

Olanzapine-associated neuroleptic malignant syndrome: Is there an overlap with the serotonin syndrome?

Ann Gen Hosp Psychiatry. 2003 Oct 29;2(1):10. doi: 10.1186/1475-2832-2-10.

Olanzapine: an updated review of its use in the management of schizophrenia.

Drugs. 2001;61(1):111-61. doi: 10.2165/00003495-200161010-00011.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Recurrence of neuroleptic malignant syndrome with olanzapine treatment.

Am J Psychiatry. 1999 Nov;156(11):1836. doi: 10.1176/ajp.156.11.1836.

Olanzapine usage associated with neuroleptic malignant syndrome.

Psychosomatics. 2001 Nov-Dec;42(6):528-9. doi: 10.1176/appi.psy.42.6.528.

[Life threatening neuroleptic malignant syndrome due to olanzapine].

Psychiatr Prax. 2003 Jul;30(5):279-82. doi: 10.1055/s-2003-40681.

Olanzapine and neuroleptic malignant syndrome.

Psychosomatics. 2002 Nov-Dec;43(6):505-6; author reply 506. doi: 10.1176/appi.psy.43.6.505.

Olanzapine-induced neuroleptic malignant syndrome.

Arch Gen Psychiatry. 1999 Jan;56(1):101-2. doi: 10.1001/archpsyc.56.1.101.

Olanzapine-induced neuroleptic malignant syndrome with mental retardation.

Am J Psychiatry. 1999 Jul;156(7):1115-6. doi: 10.1176/ajp.156.7.1115a.

Neuroleptic malignant syndrome associated with olanzapine.

Ann Pharmacother. 1998 Nov;32(11):1158-9. doi: 10.1345/aph.18151.

Neuroleptic malignant syndrome associated with olanzapine.

Aust N Z J Psychiatry. 1998 Dec;32(6):884-6. doi: 10.3109/00048679809073880.

Neuroleptic malignant syndrome after addition of haloperidol to atypical antipsychotic.

Am J Psychiatry. 2001 Apr;158(4):650-1. doi: 10.1176/appi.ajp.158.4.650-a.

Olanzapine induced "typical" neuroleptic malignant syndrome.

J Clin Psychopharmacol. 2003 Feb;23(1):101-2. doi: 10.1097/00004714-200302000-00016.

引用本文的文献

Three Episodes of Neuroleptic Malignant Syndrome With Risperidone: A Case Report and Literature Review.

Case Rep Psychiatry. 2025 Sep 11;2025:6669246. doi: 10.1155/crps/6669246. eCollection 2025.

Serum creatine kinase elevation as a possible complication of therapy with olanzapine.

Naunyn Schmiedebergs Arch Pharmacol. 2005 Aug;372(2):168-9. doi: 10.1007/s00210-005-0004-7. Epub 2005 Oct 22.

Olanzapine-associated neuroleptic malignant syndrome: Is there an overlap with the serotonin syndrome?

Ann Gen Hosp Psychiatry. 2003 Oct 29;2(1):10. doi: 10.1186/1475-2832-2-10.

Olanzapine: an updated review of its use in the management of schizophrenia.

Drugs. 2001;61(1):111-61. doi: 10.2165/00003495-200161010-00011.